Genomics in Diabetic Kidney Disease: A 2024 Update

Area of Science:

• Genetics and Genomics
• Nephrology
• Endocrinology

Background:

• Diabetic Kidney Disease (DKD) is a major cause of kidney failure globally, characterized by increasing prevalence and low disease awareness.
• DKD presents significant heterogeneity in clinical manifestations and progression, complicating early diagnosis and effective treatment.
• Genetic factors are increasingly recognized as crucial contributors to DKD development and progression, alongside environmental influences.

Discussion:

• Genome-wide association studies (GWASs) have been instrumental in identifying genetic risk variants associated with DKD traits in diverse populations.
• These genetic discoveries are expanding our comprehension of the complex pathophysiological mechanisms underlying DKD.
• Understanding genetic predispositions can pave the way for personalized medicine approaches in DKD management.

Key Insights:

• Family and GWAS studies confirm a significant role for inherited genetic factors in DKD.
• GWASs have successfully pinpointed numerous genetic variants linked to DKD in both Type 1 and Type 2 diabetes.
• Genomic insights are crucial for unraveling DKD's heterogeneity and improving therapeutic strategies.

Outlook:

• Future research should focus on integrating multi-omics data with clinical information for a comprehensive understanding of DKD.
• Translating genomic findings into clinical practice for early diagnosis and targeted therapies is a key future direction.
• Continued exploration of genetic architecture will refine DKD risk prediction and treatment efficacy.